ERBB2 and breast cancer: We were surprised to find out that all papers related to HER2 + BC referred to tumor diffuse infiltrating lymphocyte (known as TIL) but not to tertiary lymphoid structures (TLSs, defined as lymphoid follicle-like structures developed in a non-lymphoid tissue) which are the aim of our study [53].